Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteers

168Citations
Citations of this article
56Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Aims To study the recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteers. Methods Ten healthy volunteers were treated with clopidogrel (75 mg day-1) for 7 days. CD62P expression and PAC-1 binding were measured by flow cytometry. Results Adenosine diphosphate (ADP, 30 (jiM)-induced platelet responses were almost completely inhibited by clopidogrel. After discontinuation of the drug, platelet function gradually increased and complete recovery was seen 7 days after the last clopidogrel dose. The mean difference (95% CI) for ADP-induced PAC-1 binding (fluorescence intensity) between baseline and 7 days after the last dose was 0.01 (0.61, -0.59). Single cell analysis provides direct evidence for an irreversible mode of action of clopidogrel. Conclusions This is the first report to directly demonstrate irreversibility of clopidogrel action in humans. ©2001 Blackwell Science Ltd.

Author supplied keywords

Cite

CITATION STYLE

APA

Weber, A. A., Braun, M., Hohlfeld, T., Schwippert, B., Tschöpe, D., & Schrör, K. (2001). Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteers. British Journal of Clinical Pharmacology, Supplement, 52(3), 333–336. https://doi.org/10.1046/j.0306-5251.2001.01453.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free